Presenilins, Deranged Calcium Homeostasis, Synaptic Loss and Dysfunction in Alzheimer's Disease
暂无分享,去创建一个
Ilya Bezprozvanny | I. Bezprozvanny | C. Supnet | Charlene Supnet | Elena Popugaeva | St Petersburg | E. Popugaeva | S. Petersburg
[1] Jae Woong Lee,et al. PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] Phillip B. Jones,et al. Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. , 2007, The American journal of pathology.
[3] T. Bliss,et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice , 1999, Nature Neuroscience.
[4] W. Klein,et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[5] C. Epstein,et al. Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12. , 2005, Mammalian genome : official journal of the International Mammalian Genome Society.
[6] John Hardy,et al. The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal , 2009, Journal of neurochemistry.
[7] E. Godaux,et al. Mutant Presenilins Disturb Neuronal Calcium Homeostasis in the Brain of Transgenic Mice, Decreasing the Threshold for Excitotoxicity and Facilitating Long-term Potentiation* , 2001, The Journal of Biological Chemistry.
[8] R. Nicoll,et al. Expression Mechanisms Underlying NMDA Receptor‐Dependent Long‐Term Potentiation , 1999, Annals of the New York Academy of Sciences.
[9] D. Holtzman,et al. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.
[10] J. Herms,et al. Role of presenilin1 in structural plasticity of cortical dendritic spines in vivo , 2011, Journal of neurochemistry.
[11] Menahem Segal,et al. Dendritic spines shaped by synaptic activity , 2000, Current Opinion in Neurobiology.
[12] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[13] V. Nimmrich,et al. Is Alzheimer's Disease a Result of Presynaptic Failure? - Synaptic Dysfunctions Induced by Oligomeric β-Amyloid , 2009, Reviews in the neurosciences.
[14] M. Mattson,et al. Hippocampal Spatial Memory Impairments Caused by the Familial Alzheimer’s Disease-Linked Presenilin 1 M146V Mutation , 2005, Neurodegenerative Diseases.
[15] G. Turrigiano,et al. Rapid Synaptic Scaling Induced by Changes in Postsynaptic Firing , 2008, Neuron.
[16] D. Peterson,et al. Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice , 2002, The Journal of Neuroscience.
[17] K. Oka,et al. Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Selkoe,et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. , 1992, Nature.
[19] M. Matsuzaki. Factors critical for the plasticity of dendritic spines and memory storage , 2007, Neuroscience Research.
[20] C. Cotman,et al. Calcium, membranes, aging, and Alzheimer's disease , 1989 .
[21] F. Kirchhoff,et al. Reduced Spine Density in Specific Regions of CA1 Pyramidal Neurons in Two Transgenic Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.
[22] I. Bezprozvanny,et al. Familial Alzheimer's disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes. , 2010, Journal of Alzheimer's disease : JAD.
[23] Allan I. Levey,et al. Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.
[24] M. Frosch,et al. Presenilin-Mediated Modulation of Capacitative Calcium Entry , 2000, Neuron.
[25] H. Kretzschmar,et al. γ-Secretase Inhibition Reduces Spine Density In Vivo via an Amyloid Precursor Protein-Dependent Pathway , 2009, The Journal of Neuroscience.
[26] T. Sacktor,et al. Protein synthesis-dependent formation of protein kinase Mzeta in long- term potentiation , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[27] A. Peters,et al. The small pyramidal neuron of the rat cerebral cortex. The perikaryon, dendrites and spines. , 1970, The American journal of anatomy.
[28] Ivan V. Goussakov,et al. NMDA-Mediated Ca2+ Influx Drives Aberrant Ryanodine Receptor Activation in Dendrites of Young Alzheimer's Disease Mice , 2010, The Journal of Neuroscience.
[29] M. Mattson,et al. Presenilin-1 Mutations Increase Levels of Ryanodine Receptors and Calcium Release in PC12 Cells and Cortical Neurons* , 2000, The Journal of Biological Chemistry.
[30] A. Alpár,et al. Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice , 2006, Brain Research.
[31] D. Selkoe,et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.
[32] B. de Strooper,et al. Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. , 2003, Neuron.
[33] T. Pozzan,et al. Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia , 2005, Neurobiology of Disease.
[34] M. Mattson,et al. Progressive age-related impairment of the late long-term potentiation in Alzheimer's disease presenilin-1 mutant knock-in mice. , 2010, Journal of Alzheimer's disease : JAD.
[35] F. LaFerla,et al. Enhanced Ryanodine Receptor Recruitment Contributes to Ca2+ Disruptions in Young, Adult, and Aged Alzheimer's Disease Mice , 2006, The Journal of Neuroscience.
[36] R. Malinow,et al. APP Processing and Synaptic Function , 2003, Neuron.
[37] C. Cotman,et al. Alzheimer's Presenilin‐1 Mutation Potentiates Inositol 1,4,5‐Trisphosphate‐Mediated Calcium Signaling in Xenopus , 1999, Journal of neurochemistry.
[38] T. Südhof,et al. Presenilins are Essential for Regulating Neurotransmitter Release , 2009, Nature.
[39] Ivan V. Goussakov,et al. Deviant Ryanodine Receptor-Mediated Calcium Release Resets Synaptic Homeostasis in Presymptomatic 3xTg-AD Mice , 2009, The Journal of Neuroscience.
[40] Panteleimon Giannakopoulos,et al. Pathological substrates of cognitive decline in Alzheimer's disease. , 2009, Frontiers of neurology and neuroscience.
[41] Jean Mariani,et al. Age-Dependent Impairment of Spine Morphology and Synaptic Plasticity in Hippocampal CA1 Neurons of a Presenilin 1 Transgenic Mouse Model of Alzheimer's Disease , 2009, The Journal of Neuroscience.
[42] T. Iwatsubo,et al. Gain-of-Function Enhancement of IP3 Receptor Modal Gating by Familial Alzheimer’s Disease–Linked Presenilin Mutants in Human Cells and Mouse Neurons , 2010, Science Signaling.
[43] B. Strooper,et al. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.
[44] Alan Peters,et al. THE SMALL PYRAMIDAL NEURON OF THE RAT CEREBRAL CORTEX , 1968, Zeitschrift für Zellforschung und Mikroskopische Anatomie.
[45] Phillip B. Jones,et al. A Reporter of Local Dendritic Translocation Shows Plaque- Related Loss of Neural System Function in APP-Transgenic Mice , 2009, The Journal of Neuroscience.
[46] M. Berridge. Neuronal Calcium Signaling , 1998, Neuron.
[47] Tara Spires-Jones,et al. Amyloid β Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation , 2010, The Journal of Neuroscience.
[48] E. Kandel,et al. Recruitment of long-lasting and protein kinase A-dependent long-term potentiation in the CA1 region of hippocampus requires repeated tetanization. , 1994, Learning & memory.
[49] Jian Zhou,et al. Critical role of TRPC6 channels in the formation of excitatory synapses , 2008, Nature Neuroscience.
[50] C. Cotman,et al. Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress , 2007, Neurobiology of Disease.
[51] R. Malinow,et al. Enhanced Synaptic Potentiation in Transgenic Mice Expressing presenilin 1 Familial Alzheimer's Disease Mutation Is Normalized with a Benzodiazepine , 2000, Neurobiology of Disease.
[52] M. Mattson,et al. Capacitative Calcium Entry Deficits and Elevated Luminal Calcium Content in Mutant Presenilin-1 Knockin Mice , 2000, The Journal of cell biology.
[53] T. Bliss,et al. A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.
[54] W. Abraham,et al. Inhibition of protein synthesis in the dentate gyrus, but not the entorhinal cortex, blocks maintenance of long-term potentiation in rats , 1989, Neuroscience Letters.
[55] Ilya Bezprozvanny,et al. Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[56] William J Ray,et al. Beyond amyloid: the next generation of Alzheimer's disease therapeutics. , 2007, Molecular interventions.
[57] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[58] T. Spires,et al. Neuronal Structure is Altered by Amyloid Plaques , 2004, Reviews in the neurosciences.
[59] Scott A. Small,et al. Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis , 2008, Neuron.
[60] Roberto Malinow,et al. Amyloid beta from axons and dendrites reduces local spine number and plasticity , 2010, Nature Neuroscience.
[61] Brian J. Bacskai,et al. Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal Networks , 2008, Neuron.
[62] L. Schiapparelli,et al. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels , 2009, Neurobiology of Disease.
[63] F. LaFerla,et al. Enhanced caffeine‐induced Ca2+ release in the 3xTg‐AD mouse model of Alzheimer's disease , 2005, Journal of neurochemistry.
[64] T. Bliss,et al. Remodelling of synaptic morphology but unchanged synaptic density during late phase long-term potentiation(ltp): A serial section electron micrograph study in the dentate gyrus in the anaesthetised rat , 2004, Neuroscience.
[65] I. Bezprozvanny,et al. The dysregulation of intracellular calcium in Alzheimer disease. , 2010, Cell calcium.
[66] John Hardy,et al. Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.
[67] Grace E. Stutzmann. The Pathogenesis of Alzheimers Disease—Is It a Lifelong “Calciumopathy”? , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[68] D. Linden,et al. Synaptic Transmission and Hippocampal Long-Term Potentiation in Transgenic Mice Expressing FAD-Linked Presenilin 1 , 1999, Neurobiology of Disease.
[69] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[70] W. Klein,et al. Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.
[71] Z. Khachaturian. Introduction and Overview , 1989, Annals of the New York Academy of Sciences.
[72] P. Somogyi,et al. NMDA Receptor Content of Synapses in Stratum Radiatum of the Hippocampal CA1 Area , 2000, The Journal of Neuroscience.
[73] T. Südhof,et al. Inactivation of presenilins causes pre-synaptic impairment prior to post-synaptic dysfunction , 2010, Journal of neurochemistry.
[74] L. Mucke,et al. Synaptic Depression and Aberrant Excitatory Network Activity in Alzheimer’s Disease: Two Faces of the Same Coin? , 2010, NeuroMolecular Medicine.
[75] V. Lee,et al. Mechanism of Ca2+ Disruption in Alzheimer's Disease by Presenilin Regulation of InsP3 Receptor Channel Gating , 2008, Neuron.
[76] W. Klein,et al. Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 , 2010, Neuron.
[77] B. Strooper,et al. Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked Mutations , 2006, Cell.
[78] Kang Hu,et al. High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.
[79] Y. Goda,et al. Unraveling Mechanisms of Homeostatic Synaptic Plasticity , 2010, Neuron.
[80] G. Wenk,et al. Neuropathologic changes in Alzheimer's disease. , 2003, The Journal of clinical psychiatry.
[81] K. Svoboda,et al. Experience-dependent structural synaptic plasticity in the mammalian brain , 2009, Nature Reviews Neuroscience.
[82] Kristen M Harris,et al. Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders? , 2002, Brain Research Reviews.
[83] S. B. Kater,et al. Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. , 1994, Annual review of neuroscience.
[84] Bernardo L Sabatini,et al. Anatomical and physiological plasticity of dendritic spines. , 2007, Annual review of neuroscience.
[85] Ian Parker,et al. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. , 2008, The Journal of general physiology.
[86] B. de Strooper,et al. Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons , 1999, The Journal of cell biology.
[87] J. Bourne,et al. Balancing structure and function at hippocampal dendritic spines. , 2008, Annual review of neuroscience.
[88] Mu-ming Poo,et al. Shrinkage of Dendritic Spines Associated with Long-Term Depression of Hippocampal Synapses , 2004, Neuron.
[89] Petter Laake,et al. Different modes of expression of AMPA and NMDA receptors in hippocampal synapses , 1999, Nature Neuroscience.
[90] K. Svoboda,et al. Structure and function of dendritic spines. , 2002, Annual review of physiology.
[91] C. Epstein,et al. Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(1716)65Dn and mouseChromosome 12 , 2005, Mammalian Genome.
[92] B. Strooper,et al. Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex , 2003, Neuron.
[93] Ilya Bezprozvanny,et al. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease , 2008, Trends in Neurosciences.
[94] J. Bourne,et al. Do thin spines learn to be mushroom spines that remember? , 2007, Current Opinion in Neurobiology.
[95] G. Turrigiano. The Self-Tuning Neuron: Synaptic Scaling of Excitatory Synapses , 2008, Cell.
[96] F. LaFerla,et al. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production , 2008, The Journal of cell biology.
[97] E. Godaux,et al. Modulation of synaptic plasticity and Tau phosphorylation by wild-type and mutant presenilin1 , 2008, Neurobiology of Aging.
[98] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[99] Grace E Stutzmann,et al. Dysregulated IP3 Signaling in Cortical Neurons of Knock-In Mice Expressing an Alzheimer's-Linked Mutation in Presenilin1 Results in Exaggerated Ca2+ Signals and Altered Membrane Excitability , 2004, The Journal of Neuroscience.
[100] H. Kretzschmar,et al. Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein , 2006, The Journal of Neuroscience.
[101] C. Epstein,et al. Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome , 2004, The Journal of comparative neurology.
[102] B. Bergmans,et al. γ-secretases: from cell biology to therapeutic strategies , 2010, The Lancet Neurology.
[103] E. Jazin,et al. Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling , 2006, Neurobiology of Disease.
[104] J. Herms,et al. Role of APP for dendritic spine formation and stability , 2011, Experimental Brain Research.
[105] K. Pratt,et al. Presenilin 1 Regulates Homeostatic Synaptic Scaling Through Akt Signaling , 2011, Nature Neuroscience.
[106] P. Andersen,et al. Long-term potentiation is associated with new excitatory spine synapses on rat dentate granule cells. , 1996, Learning & memory.
[107] B. de Strooper,et al. Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. , 2007, The Journal of clinical investigation.
[108] S. DeKosky,et al. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.